Custom impurity synthesis and non-catalogue compound review for global pharmaceutical, CRO, analytical, and sourcing teams.
Some pharmaceutical impurities, metabolites, degradants, intermediates, and NDSRI targets are not available as catalogue materials. Swapreen Pharma reviews custom synthesis enquiries from overseas buyers when the target identity, structure, scale, purity target, and timeline are clearly defined.
Share the exact compound name, pharmacopeial designation where relevant, CAS number or structure if known, requested quantity, target purity, destination country, intended application, documentation needs, and preferred timeline. Our India-based export team will review the API impurities, working standards, reference standards, intermediates, or custom synthesis requirement and reply with quotation guidance.
Rare API Impurities — Technical review for process impurities, degradants, and related substances not available in standard catalogues.
Metabolites and Degradants — Defined research compounds can be assessed for analytical development and investigative programs.
NDSRI Targets — Drug substance-related nitrosamine impurity targets can be reviewed with structure and API context.
Custom Intermediates — Specialized intermediates and building blocks can be assessed against route, scale, and purity needs.
A technically complete request helps us assess catalogue availability, working standards requirements, or custom synthesis feasibility efficiently.
Share structure, CAS number, impurity designation, reference document, or SMILES where available.
Mention API, product, QC, validation, stability, research, or regulatory-support context.
State milligram, gram, or larger scale requirement and repeat forecast if relevant.
Provide desired purity, analytical method expectations, and acceptance criteria where known.
List CoA, HPLC, NMR, MS, IR, SDS, or characterization requirements.
Share destination country/city and required quotation or delivery planning timeline.
Yes. Clearly defined rare impurities, metabolites, degradants, NDSRIs, and intermediates can be reviewed for custom synthesis feasibility.
A structure or reference, target identity, requested scale, purity target, intended use, documentation needs, destination, and timeline are essential.
Yes. Export buyers can submit technical details and destination information for review from India.
Yes. NDSRI targets can be reviewed when the structure, associated drug substance, required scale, and analytical context are provided.
Send your compound details, destination country, quantity, purity target, intended use, documentation needs, and timeline. Our manufacturer and exporter from India team will review your API impurity, working standard, reference standard, intermediate, or custom synthesis requirement and respond with the next practical step.